Top

Journal of Assisted Reproduction and Genetics

Published in:

01-03-2012 | Fertility Preservation

Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe?

Authors: Vasileios D. Sioulas, Clarisa R. Gracia

Published in: Journal of Assisted Reproduction and Genetics | Issue 3/2012

Abstract

Objective

To report the first case of using assisted reproductive technologies (ART) for fertility preservation in a patient with mixed connective tissue disease (MCTD), secondary pulmonary hypertension (PH) and antiphospholipid syndrome (APS).

Design

Case-report and review of the literature.

Setting

Academic infertility practice and tertiary care center.

Patient(s)

A 25-year-old woman with MCTD, complicated with PH and APS, who was scheduled for gonadotoxic therapy

Intervention(s)

Controlled ovarian hyperstimulation, egg retrieval, embryo banking.

Main outcome measure(s)

Successful ART cycle leading to embryo banking without worsening her underlying disease.

Result(s)

Following successful embryo cryopreservation, the patient experienced respiratory failure and other severe complications, resulting in a prolonged hospital stay.

Conclusion(s)

Controlled ovarian hyperstimulation for embryo banking in women with MCTD, PH and APS may pose a risk for potentially catastrophic complications. A multidisciplinary approach to these patients is necessary to optimize the outcomes of such procedures. More data are needed regarding the safety of fertility preservation technologies in patients with complex medical diseases.

Venables PJ. Mixed connective tissue disease. Lupus. 2006;15:132–7.PubMedCrossRef

Kitridou RC. Pregnancy in mixed connective tissue disease. Rheum Dis Clin North Am. 2005;31:497–508. vii.PubMedCrossRef

Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30:256–65.PubMedCrossRef

Elizur SE, Chian RC, Pineau CA, Son WY, Holzer HE, Huang JY, et al. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents. Rheumatology (Oxford). 2008;47:1506–9.CrossRef

Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol. 1988;6:813–8.PubMed

Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus eryuthematosus and antiphospholipid syndrome. Fertil Steril. 2009;92:1803–10.PubMedCrossRef

Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010;94:389–400.PubMedCrossRef

Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290:66–72.PubMedCrossRef

Lee J, Yim JJ, Yang SC, Yoo CG, Kim YW, Han SK et al. Outcome of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int. 2011: doi:10.1007/s00296-011-2158-6.

10.

Walker SE. Estrogen and autoimmune disease. Clin Rev Allergy Immunol. 2011;40:60–5.PubMedCrossRef

11.

González DA, Díaz BB, Rodríguez Pérez Mdel C, Hernández AG, Chico BN, de León AC. Sex hormones and autoimmunity. Immunol Lett. 2010;133:6–13.PubMedCrossRef

12.

Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum. 2000;43:550–6.PubMedCrossRef

13.

Huong DL, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Lefebvre G, et al. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum. 2002;32:174–88.PubMedCrossRef

14.

Ishihara O, Saitoh M, Hayashi N, Kinoshita K, Takeuchi T. Successful treatment of embryo implantation failure in patients with the Sjögren syndrome with low-dose prednisolone. Fertil Steril. 2001;75:640–1.PubMedCrossRef

15.

Sills ES, Perloe M, Tucker MJ, Kaplan CR, Palermo GD. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol. 2001;46:366–8.PubMedCrossRef

16.

Chua S, Viegas OA, Tan AT, Ratnam SS. Successful outcome of pregnancy in a subfertile patient with severe aortoarteritis (Takayasu’s disease). Eur J Obstet Gynecol Reprod Biol. 1987;25:249–53.PubMedCrossRef

17.

Lazúrová I, Angelovicová J, Petríková J, Calfová A, Oetterová M, Svajdler M. A case of polymyositis and vasculitis induced by ovulation induction therapy with gonadotropin-releasing hormone. Clin Rheumatol. 2010;29:1327–30.PubMedCrossRef

18.

Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol. 2003;176:293–304.PubMedCrossRef

19.

Galiè N, Hoeper MM, Humbert MM, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493–537.PubMedCrossRef

20.

Coghlan JG, Pope J, Denton CP. Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease. Curr Opin Pulm Med. 2010;16 Suppl 1:S27–34.PubMedCrossRef

21.

Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S43–54.PubMedCrossRef

22.

Pugh ME, Hemnes AR. Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease. Womens Health (Lond Engl). 2010;6:285–96.CrossRef

23.

Umar S, Iorga A, Matori H, Nadadur RD, Li J, Maltese F, et al. Estrogen rescues pre-existing severe pulmonary hypertension in rats. Am J Respir Crit Care Med. 2011;184:715–23.PubMedCrossRef

24.

Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol. 2006;35:468–71.PubMedCrossRef

25.

Scorza R, Caronni M, Bazzi S, Nador F, Beretta L, Antonioli R, et al. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci. 2002;966:238–46.PubMedCrossRef

26.

Sweeney L, Voelkel NF. Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension. Eur J Med Res. 2009;14:433–42.PubMed

27.

Morse JH, Horn EM, Barst RJ. Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertension. Chest. 1999;116:847.PubMedCrossRef

28.

Metzler E, Ginsburg E, Tsen LC. Use of assisted reproductive technologies and anesthesia in a patient with primary pulmonary hypertension. Fertil Steril. 2004;81:1684–7.PubMedCrossRef

29.

Price LC, Montani D, Jaïs X, Dick JR, Simonneau G, Sitbon O, et al. Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J. 2010;35:1294–302.PubMedCrossRef

30.

Pritts CD, Pearl RG. Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol. 2010;23:411–6.PubMedCrossRef

31.

Lane MA, Devine ST, McDonald JR. High-risk antimicrobial prescriptions among ambulatory patients on warfarin. J Clin Pharm Ther. 2011: doi:10.1111/j.1365-2710.2011.01270.x.

Title: Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe?
Authors: Vasileios D. Sioulas
Clarisa R. Gracia
Publication date: 01-03-2012
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 3/2012
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-011-9697-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe?

Abstract

Objective

Design

Setting

Patient(s)

Intervention(s)

Main outcome measure(s)

Result(s)

Conclusion(s)

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design

Setting

Patient(s)

Intervention(s)

Main outcome measure(s)

Result(s)

Conclusion(s)

Please log in to get access to this content

Other articles of this Issue 3/2012

Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report

Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization

Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women

When ONE is the not-so-loneliest number!

Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial

Epigenetics and its role in male infertility